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Anemia prevalence in children is high, especially in developing countries (DeMaeyer and Adiels-Tegman 1985) and
frequently is multifactorial. It is often associated with childhood malnutrition, producing interlinked factors, several of
which could be causally related to mortality risk. These factors
include lack of hematinics (e.g., iron, folate, vitamins A, B-12
and C, and copper), impairment of red cell production by
acute or subacute inflammation (with an increase in stored
iron) and increased red cell destruction either via specific
infections (e.g., malaria) or specific nutrients (e.g., vitamin
A). How is anemia associated with these factors related to
child mortality? Is there a hierarchy of importance? What

●

iron deficiency
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ABSTRACT The relationship of anemia as a risk factor for child mortality was analyzed by using cross-sectional,
longitudinal and case-control studies, and randomized trials. Five methods of estimation were adopted: 1) the
proportion of child deaths attributable to anemia; 2) the proportion of anemic children who die in hospital studies;
3) the population-attributable risk of child mortality due to anemia; 4) survival analyses of mortality in anemic
children; and 5) cause-specific anemia-related child mortality. Most of the data available were hospital based. For
children aged 0 –5 y the percentage of deaths due to anemia was comparable for reports from highly malarious
areas in Africa (Sierra Leone 11.2%, Zaire 12.2%, Kenya 14.3%). Ten values available for hemoglobin values ⬍50
g/L showed a variation in case fatality from 2 to 29.3%. The data suggested little if any dose-response relating
increasing hemoglobin level (whether by mean value or selected cut-off values) with decreasing mortality. Although
mortality was increased in anemic children with hemoglobin ⬍50 g/L, the evidence for increased risk with less
severe anemia was inconclusive. The wide variation for mortality with hemoglobin ⬍50 g/L is related to methodological variation and places severe limits on causal inference; in view of this, it is premature to generate projections
on population-attributable risk. A preliminary survival analysis of an infant cohort from Malawi indicated that if the
hemoglobin decreases by 10 g/L at age 6 mo, the risk of dying becomes 1.72 times higher. Evidence from a number
of studies suggests that mortality due to malarial severe anemia is greater than that due to iron-deficiency anemia.
Data are scarce on anemia and child mortality from non-malarious regions. Primary prevention of iron-deficiency
anemia and malaria in young children could have substantive effects on reducing child mortality from severe
anemia in children living in malarious areas. J. Nutr. 131: 636S– 648S, 2001.

mechanisms could lead from these nutrient deficiencies, especially iron deficiency, to higher mortality? Although there is a
sense that severe anemia will increase mortality risk, how
substantial is the evidence related to mild or moderate anemia?
The purpose of this analysis is to review the contribution of
iron-deficiency anemia to child mortality and to estimate the
magnitude of that effect. In view of the above framework, an
analysis of this nature is limited in the absence of an appropriately defined hypothesis (Palloni 1987). Iron-deficiency
anemia could interact with mortality in several ways, some of
which may even be advantageous (Bullen and Griffiths 1999).
The proposition that childhood anemia increases mortality
risk is open to evaluation mainly through cross-sectional and
case-control studies, and the data available have not been
derived on the basis of testing established hypotheses. For
example, analysis of the National Nutrition Status Survey of
Zambia identified significant interactions between the hemoglobin (Hb)4 level of the youngest child in a family with the
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social factors associated with child death rates (e.g., intertribal
marriage or lack of parental education), but the mechanisms
governing these associations were unknown (Wenlock 1979).
Only one intervention study includes an evaluation of
infant mortality in relation to iron supplementation (AlonsoGonzalez et al. 2000). Additional trials with mortality outcomes, from trials in toddlers with iron-deficiency anemia to
preventive trails in younger infants to trials in school children
with iron-deficiency anemia, have not been identified (S.
Logan, Institute of Child Health, London, personal communication). Within the framework of these limitations, the
methods adopted in this analysis of anemia as a risk factor for
child deaths include the following: 1) the proportion of child
deaths attributable to anemia; 2) the proportion of anemic
children who die in hospital studies; 3) the population-attributable risk of child mortality due to anemia; 4) survival analyses of mortality in anemic children; and 5) cause-specific
anemia-related child mortality.
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TABLE 1
Estimated anemia deaths (in thousands) in children1
Males

Females

Region

0–4 y

5–14 y

0–4 y

5–14 y

Developed (all)
Developing (all)
Established market economies
Formerly socialist economies
India
China
Other Asia and islands
Sub-Saharan Africa
Latin America and Caribbean
Middle Eastern crescent
World

—
19.9
—
—
6.4
1.6
2.9
4.3
1.5
3.3
20.1

—
6.0
—
—
1.3
—
1.2
1.1
—
—
6.2

—
16.2
—
—
5.3
4.8
1.4
1.9
1.1
1.8
16.4

—
23.0
—
—
7.2
2.3
4.6
4.9
—
3.3
23.2

METHODS
Identification of published studies. Published studies on the
relationship between anemia (defined by severity) and childhood
mortality were identified using Medline, references in published papers, Cochrane Review issues and personal communications. Only
hospital or community studies in developing countries were considered.
Selection of studies for inclusion in the analyses. Studies identified were reviewed with regard to the following factors: ages of
children (up to 12 y), anemia severity, clinical presentation data, use
of blood transfusion, length of follow-up, etiological diagnosis, laboratory estimation of Hb or hematocrit, and analytical methods. Hematocrit was converted to a Hb value by dividing by 3 and multiplying by 10. Studies stating that anemia was a direct cause of death were
of particular value, permitting the estimate of the total number of
child deaths attributed to anemia. Of the studies identified, 10 provided data for which Hb midpoint values could be calculated. All
other studies used anemia cut-off points below which proportional
groups of children with anemia were defined.
Definitions. Mild anemia was defined as Hb ⬍110 g/L, moderate
anemia as ⬍70 g/L and severe anemia as ⬍50 g/L. The 110 g/L cut-off
value is based on international convention, whereas the other two
cut-off values are commonly used in the literature.
Analyses. For each of the studies selected, estimates of the
relative risks (RR) and their 95% confidence intervals (CI) were
calculated using established methods (Kleinbaum 1982). Several case
fatality studies could not be used in the risk analysis because they did
not present mortality data for the less anemic subjects in their study
population. Because the greatest number of studies were stratified by
Hb ⬍50 g/L, this criterion was used for inclusion of individual studies
in pooled analyses.
Relative risk values were estimated and the relationship between
anemia severity and mortality risk was analyzed by curve fitting
(linear, quadratic, exponential) and coefficients of determination (R2
values) were calculated. These were used with prevalence estimates to
obtain the population-attributable risk (PAR) of anemia-related
child mortality as follows:
PAR ⫽ deaths related to anemia/total deaths
⫽ 关Prev ⫻ 共RR ⫺ 1兲兴/兵1 ⫹ 关Prev ⫻ 共RR ⫺ 1兲兴其
where Prev is the prevalence of anemia and RR is the ratio of
mortality in anemic subjects to mortality in less anemic subjects.
Results from an iron supplementation and malaria chemoprophylaxis trial reported by Menendez et al. (1997) and the prospective
descriptive study by Zucker et al. (1996) were used to estimate years
of life lost because of anemia related to iron deficiency, malaria and
other causes.

RESULTS
The proportion of child deaths attributable to anemia
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1 Source reference: Murray and Lopez (1994). A dash (—) indicates
⬍1000 deaths.

Anemia is now recognized as an important cause of morbidity and mortality in African children admitted to hospitals
but is rarely cited as a cause of death outside hospitals (Awashi
and Pande 1998). This is probably because the diagnosis of
anemia by verbal autopsy and morbidity interviews in the
community is unusual and unreliable (Alonso et al. 1987,
Belcher et al. 1976). In a prospective study in the Gambia, the
sensitivity, specificity and predictive value of verbal autopsy
interviews for anemia compared with hospital-derived diagnoses were 33, 98 and 50%, respectively (Snow et al. 1992).
The pattern of deaths attributable to anemia will also vary by
child’s age because clinical severity is greater in young children
(De Maeyer and Adiels-Tegman 1985, Le Cessie et al., unpublished data, 2000). Epidemiologic studies in the Gambia
have shown that the marked seasonal variations that occurred
in clinical malaria and malaria parasitemia were associated
with similar variations in the prevalence and severity of childhood anemia (McGregor et al. 1966). Furthermore, peak mortality in young children occurred seasonally when malaria and
anemia were most prevalent (Ian McGregor, personal communication).
Table 1 shows the number of deaths attributed to anemia
(all forms) in hospital and nonhospital settings summarized by
the Global Burden of Disease Group and published by the
World Health Organization (Murray and Lopez 1994). The
greatest burden is in females in developing countries, and
regionally the highest estimates are for India and then subSaharan Africa. Younger males and older females are at highest risk of death.
Table 2 shows the proportion of deaths related to anemia
for several African and one Indian report. All are hospital
based except the study from Zaire, which was a prospective
rural community study in a random cluster sample of 5167
children. All are from malarious areas, except for the study
from Agra in India, which attributed only 2% of admissions
and 0.2% of deaths to malaria. For children 0 –5 y of age, the
percentage of deaths due to anemia is similar for reports from
highly malarious areas, i.e., Sierra Leone (11.2%), Zaire
(12.2%) and Kenya (14.3%). These estimates are higher than
those for children ⬍5 y old from urban Kampala, where
malaria transmission is not intense. A lower proportion of

SUPPLEMENT

638S

TABLE 2
Anemia as a cause of death in children in developing countries
Country

Type of study

Years

Retrospective hospital and
autopsies

1967–68

Sierra
Leone
(Freetown)
India (Agra)

City death registry

1969–79
1987–91

Retrospective hospital
admissions
Retrospective hospital
admissions
Prospective community
Prospective hospital
emergency room
Prospective hospital

Zimbabwe
(Harare)
Zaire
(Bwamanda)
Ghana
(Accra)
Kenya
(Siaya)
Malawi5
Gambia
1
2
3
4
5

Prospective hospital
Mangochi
Blantyre
Prospective hospital

Deaths

Anemia as a
cause of death1

n

n (%)

1969–78

1–12 mo
1–5 y
All ages
1–4 y
0–12 mo
0–5 y
0–5 y

224
372
871
3825
2419
1845
1327

15 (6.7)
30 (8.1)
53 (6.1)
176 (4.6)
193 (8.0)2
285 (15.4)2
51 (3.8)

1982

1 mo–8 y

349

10 (2.9)2

1989–91

0–5 y

246

30 (12.2)2

1991

1–12 y

446

259 (58.1)3

1991

⬍5 y

265 (with follow-up)
265 (no follow-up)

1990–91
1990–91
1989–91

0–10 y
0–10 y
1 mo–11 y

458
1194
152

86 (32.4)2,4
38 (14.3)
43 (9.4)
77 (6.4)
7 (4.6)

Reference

Bwibo 1970
Kandeh 1986
Hodges and Williams
1995
Kalra et al. 1988
Chawla and Haufton
1988
Van Den Broeck et al.
1993
Commey and DeKyem
1995
Zucker et al. 1996
Slutsker et al. 1994
Snow et al. 1992

Severity not defined unless stated.
Anemia as primary diagnosis of cause of death.
Hb ⬍70 g/L, none transfused.
Hb ⬍50 g/L.
Excluded cases of cerebral malaria.

deaths was attributed to anemia when children ⬎5 y old were
also included, i.e., 6.1% in Uganda and 2.9% in Zimbabwe.
Only two of these studies reported anemia-related infant
deaths (4.0% in Uganda and 8.0% in Sierra Leone) (Bwibo
1970, Hodges and Williams 1998), which were less frequent
than in children 1– 4 y old.
In Kenya, the risk of dying was associated with age and Hb
level. Children who died were significantly younger (mean
⫾ SD ⫽ 9.6 ⫾ 10.2 vs. 13.4 ⫾ 10.6 mo, P ⬍ 0.0001). The
lowest risk of death from anemia was found in the two areas
with little malaria exposure (Agra, India, and Harare, Zimbabwe). The highest risks occurred with nontransfused pediatric
emergency admissions (58.1%) and in a prospective follow-up
study of a cohort of children, many of whom had chloroquineresistant malaria (Commey and DeKyem 1995, Zucker et al.
1996).
Three of these reports specify the causes of the anemiarelated deaths (Table 3). Malaria-attributable anemia occurs
in a similar proportion for the Kenyan and Ghanaian studies
(12.2 and 12.6%, respectively). Hospital deaths due to anemia
in Kenya would be expected to be much higher than those in
Ghana, where chloroquine resistance is much lower. Nutritional anemia is the predominant cause in the Ghana series
and hookworm anemia is predominant in the Ugandan series
(30.2 and 5.7%, respectively).
Within the National Health Management and Information
System in Tanzania, anemia is responsible for 17.8% deaths in
hospitalized children ⬍5 y of age. It is the second cause of
death after malaria, and the pattern of child deaths attributable to anemia changes with malaria transmission. In areas in
which malaria transmission is high (holoendemic), the anemia-attributable deaths increase. Observations in pediatric
wards also reveal that the number of blood transfusions given
increase during the peak malaria season.
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Uganda
(Kampala)

Age group

The data from Tanzania and the hospital-based data presented in Table 2 regarding anemia as a cause of death in
children in developing countries are convincing on two
points, i.e., anemia is now recognized as an important cause of
morbidity, and mortality and the association of anemia with
malaria epidemiology appear to be quite significant
The proportion of anemic children who die

Table 4 summarizes 14 studies reporting case fatality rates
for anemic children. Most children were ⬍ 5 y of age and only
one study included neonates. All were from intermediate- to
high-transmission malarious areas of Africa except for the
report from Madang, Papua New Guinea, which is also a
malarious area. Treatment schedules varied substantially
among these studies, with the percentage receiving transfusion
ranging between 0 and 100%. Across the 11 study groups that
reported the proportion of children transfused, no association
was found between case fatality rate and the percentage of
children transfused (Fig. 1). Lackritz et al. (1992), in a detailed study from Kenya reported that only children whose Hb
was ⬍ 39 g/L and who were transfused had lower mortality
than those not transfused. Above this level, transfusion was of
little benefit. This was not a randomized trial. The review of
Meremikwu and Smith (1999) of blood transfusion for treating
malarial anemia concluded that there was insufficient data to
determine whether routinely giving blood to clinically stable
children in endemic malarious areas, with severe anemia and
no respiratory distress, reduced death or results in higher
hematocrit measured at 1 mo.
No information was provided on the prevalence of irondeficiency anemia in these studies. Bojang et al. (1997) excluded children with sickle cell disease, severe malnutrition or
hemorrhage. Details of malaria parasitemia were available for
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TABLE 3
Primary diagnosis of anemia-related deaths in children1

Diagnosis

Cause of
anemia
related
death

Type of study

Reference

n (%)

1 HIV, human immunodeficiency virus; PEM, protein-energy malnutrition.

several reports because inclusion criteria depended on the
presence of parasitemia (Bojang et al. 1997, Brewster and
Greenwood 1993, Schellenberg et al. 1999, Slutsker et al.
1994). Two studies included only anemic children with malaria parasite densities ⬎10,000/L (Allen et al. 1996, Marsh
et al. 1995).
Midpoint Hb values were available for 10 of these reports.
The regression of case fatality rates against midpoint values
showed no significant association with case fatality rates. The
best line fit was for a quadratic curve that was U-shaped (R2 ⫽
19.6%, P ⫽ 0.316) (Fig. 2). The highest case fatality was
41.4% for the midpoint Hb value of 37 g/L (Lackritz et al.
1997).
The association of case fatality rates with anemia cut-off
points is shown in Figure 3. This analysis includes additional
studies that did not provide Hb midpoint values. The association remains nonsignificant with a best line fit for a logarithmic curve (R2 ⫽ 12.2%; P ⫽ 0.203). Hemoglobin and case
fatality are negatively correlated. The values available for Hb
⬍50 g/L showed a variation in case fatality from 2 to 29.3%.
Despite these differences, similarities exist among observations
from the same countries. For example, the three studies from
Tanzania show low case fatality between 2 and 7% (Holzer et
al. 1993, Schellenberg et al. 1999, Van Hombergh et al. 1996).
In the Gambia, risk was higher but similar in the two studies
from Banjul (9.6 and 13.3%) (Bojang et al. 1997, Brewster and
Greenwood 1993). In contrast, in Kenya, low risk was reported
in Kilifi in a research setting (Marsh et al. 1995) but was much

higher in Siaya in the context of routine hospital management
(Lackritz et al. 1992, Zucker et al. 1996). The proportion of
children with sickle cell disease is likely to explain some of this
variation. The pattern of association of Hb with case fatality is
similar in Figures 2 and 3 except that when the midpoint Hb
value is used, case fatality is higher in the most anemic
children.
The data provided by this analysis suggest little, if any, dose
response relating increasing Hb level (whether by mean value
or selected cut-off values) with decreasing mortality. This lack
of a dose-response relationship may be a function of the
limited range of Hb values in the populations reported. Most
of these studies are based on children admitted to hospitals,
with admission possibly dependent on their Hb level. This
selection makes it difficult to compare mortality experience
internally or externally to a group of children with better iron
status but equivalent comorbidity and underlying risk of death.
Population-attributable risk of child mortality due to
anemia
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Kenya
(deaths n ⫽ 254)
Malaria
31 (12.2) Prospective hospital Zucker et al.
Bacteremia
22 (8.7)
(admission and
1996
Malnutrition
2 (0.8)
postdischarge
HIV infection
3 (1.2)
follow-up; ⬍5 y)
Diarrhea
0 (0.0)
Pneumonia
6 (2.4)
Febrile illness
6 (2.4)
Symptomatic
9 (3.5)
anemia
0 (0.0)
Measles
2 (0.8)
Chronic diarrhea
81 (32.0)
All
Ghana
(deaths n ⫽ 259)
Nutritional anemia 135 (52.1) Pediatric emergency Commey and
Severe malaria
56 (21.6)
room (1–12 y)
DeKyem
Sickle cell anemia
28 (10.8)
1995
PEM
22 (8.5)
Gastroenteritis/
18 (6.9)
pneumonia/meningitis
Uganda
(deaths n ⫽ 596)
Hookworm anemia 34 (5.7) Retrospective
Bwibo 1970
Sickle cell anemia
11 (1.8)
hospital (1 mo–5
y)
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Table 5 compares the RR of mortality in anemic children
with their less anemic counterparts (RR A) and with the least
anemic referent group available across all studies (RR B).
Regression analysis showed no association between the values
for RR A and Hb cut-off values (R2 ⫽ 5.0%; P ⫽ 0.74). This
may result because the risk of death is still substantial in the
less anemic groups. The most frequent cut-off value for anemic
children was ⬍50 g/L. The pooled Mantel Haenszel weighted
RR for the six studies with this anemia cut-off value was 1.92
(95% CI: 1.69 –2.18), indicating a substantially increased risk
of death in severely anemic children.
Figure 4 shows the logarithmic regression of Hb cut-off
points against RR B. There is an increased risk of death in
children with Hb values ⬍80 g/L. The association does not
reach statistical significance (R2⫽ 13.8%; P ⫽ 0.156). This
arises in part because of low mortality (⬍2%) in three studies
(Allen et al. 1996, Bojang et al. 1997, Holzer et al. 1993).
These were from centers with active research groups offering
greater staff support for optimal management. Of the 16 studies available for calculation of RR B, 12 showed significantly
increased risk ratios. Those with nonsignificant values had
smaller sample sizes. In the two reports from Siaya, Kenya,
severely anemic children showed a 12-fold increased mortality
risk. The Mantel-Haenszel weighted RR for the 10 studies
using the ⬍50 g/L cut-off value was 6.07 (95% CI: 5.2–7.1).
However, the RR of mortality (Fig. 4) for the Hb cut-off value
of ⬍50 g/L shows extreme variation. The wide variation
among the different studies is likely related to methodological
variation, thus placing severe limits on causal inference. Given
the general weakness in the causal evidence relating most
iron-deficiency anemia in young children to mortality, it is
premature to generate projections regarding population-attributable risk. However, such estimates, based on the risk values
in this analysis, would be substantial.
From a public health point of view, it is necessary to know
the risk factors in the different studies for developing severe
anemia. Studies along the coast of Tanzania have identified
fever, parasitemia and age of the child as predictive factors for
anemia (Premji et al. 1995). Hedberg et al. (1993) also showed
that the population-attributable risk and OR for factors associated with anemia requiring hospitalization were also significant for low socioeconomic status and malnutrition. Evidence
from population-based studies in Tanzania and the Gambia on
malaria control in relation to change in Hb values and child
mortality after community interventions were also reviewed
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TABLE 4
Childhood hemoglobin (Hb) levels and case fatality
Year

1991
1989–91

Location

Kenya
(Siaya)
Kenya
(Siaya)

Age

⬍5 y
⬍12 y

Kenya
(Siaya)

⬍5 y

1989–91
1989–91

Kenya (Kilifi)
Kenya (Kilifi)

⬍4 y
0–5 y

1989

Tanzania
(Ifakara)
Tanzania
(Ifakara)

2 mo–6 y

1995–96

1–7 mo
8 mo–4 y

1993
1991
1990–94
1990–95
1990–91
1993–94
1988–90

Tanzania
(Turiani)
Ghana
(Accra)
Zambia
(Macha)
PNG
(Madang)
Malawi
(Mangochi)
(Blantyre)
Gambia
(Banjul)
Gambia
(Banjul)

⬍30 mo
1–12 y
5 mo–6 y
0.2–12.4 y

Deaths

Survivors

CFR1

Transfusion

g/L

n

n

%

%

⬍50
⬎50
⬍39
⬍50
⬎50
⬍50
⬍50
⬎50
⬍50
⬍50
⬍50
⬎50
⬍60
⬍60
⬍50
⬍80
⬎83
⬍50
⬍80
⬎83
⬍50

86
179
56
33
136
40
48
59
15
13
11
100
1
2
4
9
6
4
19
24
2

207
751
118
209
1499
147
68
244
305
146
110
1960
51
31
80
285
237
87
474
974
98

29.3
19.2
32.2
21.3
8.3
21.4
41.4
19.5
4.8
8.2
9.1
4.9
1.9
3.8
7.0
3.1
1.7
4.4
3.9
2.4
2.0

⬍70
⬎70
60 (mean)
92 (mean)
⬍50
⬎50
⬍50
⬍50

259
187
39
5
3
14
57
84

2212
8995
183
64
100
361
348
428

11.7
2.1
17.6
7.2
2.9
3.7
14.0
16.4

6 mo–9 y

⬍40

23

150

13.3

⬍12 y

⬍60

101

949

9.6

1 CFR, case fatality rate.

(Alonso et al. 1993, Bradley 1991). These studies reported
mean hematocrit (or packed cell volume) and not prevalence
of anemia, which restricted their use for estimation of attributable risk. Nevertheless, with reductions in malaria transmission through vector control or use of insecticide-impregnated
bed nets, substantial reductions in child mortality (in children
⬍5 y old) occurred (almost halved), which paralleled significant improvements in mean hemoglobin values.
Survival analysis in anemic children
Low birth weight is a strong predictor of mortality, and
low-birth-weight babies are also at greater risk of developing
anemia during infancy (Murray and Lopez 1994, Verhoeff et
al., unpublished, 2000). It has recently been recognized that
fetal anemia (cord Hb ⬍125 g/L) occurs frequently in developing countries (Brabin 1992). Postneonatal infant mortality
in Malawi has also been related to fetal anemia and low birth
weight. In an infant cohort study of 92 infants with low birth
weight, 120 with fetal anemia and low birth weight, and 188
with neither, those with fetal anemia and low birth weight had
the poorest survival (Verhoeff 2000). In this context, being
anemic at a young age reflects previous morbidity. This is
compounded by exposure to infection, which further increases
risk of anemia because sick children do not absorb iron well

Reference

Zucker et al. 1996
60

Lackritz et al. 1992

100
0

Lackritz et al. 1997

36
31

Marsh et al. 1995
Newton et al. 1997

100
0

Holzer et al. 1993

⬎8

40
32

Most
transfused

Schellenberg et al.
1999

Van Hombergh et
al. 1996
Commey and
KeKyem 1995
Mabeza et al. 1998
Allen et al. 1996
Slutsker et al.
1994

44
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1991

Hb

Bojang et al. 1997
Holzer et al. 1993

(Bullen and Griffiths 1999). Furthermore, children who become ill (e.g., from diarrhea) are likely to have repeated or
persistent episodes that may make them more at risk of anemia. In Brazil, anemic children were more likely to have had
diarrhea than nonanemic children, and diarrhea was a predictor of anemia in a multiple regression analysis (Ann Hill,
personal communication).
Figure 5 shows the results for a community cohort of 216
Malawian infants who had Hb values taken at 6 mo and who
did not receive iron supplements before 6 mo. The details of
the pattern of anemia in these infants has been reported by Le
Cessie et al. (unpublished data, 2000). There were 31 infants
who died who had at least one Hb measurement. The curves
are estimated from a Cox regression model and the Hb value
is entered in this model as a continuous variable. The estimated hazard ratio was 0.581 (95% CI: 0.379 – 0.888), indicating that if Hb decreases by 10 g/L, the risk of dying becomes
1.72 times higher. This relation between Hb value and survival was significant (P ⫽ 0.012). This risk was higher than
that reported by Schellenberg et al. (1999) for hospitalized
anemic children ⬍5 y of age in Tanzania who were admitted
with Hb ⬍80 g/L (a 10 g/L decrease was associated with
1.3-fold increase in the estimated OR for mortality, 95% CI:
1.04 –1.6, P ⬍ 0.02). A number of interplaying factors must be
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(OR: 0.36; 95% CI: 0.22– 0.60), which may be an indirect
effect of protection against malaria (Allen 1997, Oppenheimer
et al. 1987). In such populations, anemia may be observed to
decrease morbidity and mortality. This may be the explanation
for the observation of Oppenheimer et al. (1986) in Papua
New Guinea that birth Hb correlated positively in infants with
risk of subsequent hospital admission.
Survival of untreated children with thalassemia major hemoglobinopathies followed in Ferrara in the 1950s showed
20% survival at 3 y (WHO 1982). Usually the homozygous or
compound heterozygous state for ␤-thalassemia causes transfusion-dependent anemia from early life, although some patients run a milder course.
Cause-specific anemia and child mortality

FIGURE 2 Case fatality rates and midpoint hemoglobin (Hb) values in anemic children. Y ⫽ 68.4 ⫺ 18.2X ⫹ 1.34X2; R2 ⫽ 19.6%; P
⫽ 0.316. CI, confidence interval.

FIGURE 3 Case fatality rates in relation to Hb cut-off points in
anemic children. At Hb ⬍50 g/L, there are nine plots, two of which
overlap and are hidden.

FIGURE 1 Case fatality rates in severely anemic children in 10
studies reporting transfusion frequency. R2 ⫽ 3.4%; P ⫽ 0.589. CI,
confidence interval.

Downloaded from jn.nutrition.org at Kenya: ASNA Sponsored on April 27, 2015

controlled for in this model (e.g., low birth weight or anthropometric indexes), but the sample size was small.
Survival rates of severely anemic children (Hb ⬍50 g/L)
after admission to hospital have been reported in Kenya by
Lackritz et al. (1992) and in the Gambia by Bojang et al
(1997). In Kenya, 20.0% (158 of 768) of children died in the
first 24 h, although 51.0% received transfusion and 7.3%
(37/506) died in the next 24 h, 46.8% of whom received
transfusion. In the Gambia, Zucker et al. (1996) reported
survival after discharge of children admitted to hospital in
Kenya with severe anemia. Severely anemic children (Hb ⬍50
g/L) had higher mortality at both 1 and 2 mo postdischarge
than did children who were not severely anemic (1 mo: 14.5
vs. 8.6%; 2 mo: 18.8 vs. 11.3%). In the Malawian community
cohort, of the infants who died, there was a higher risk of dying
within 1–3 wk if the Hb was ⬍ 80 g/L.
In communities in which ␣-thalassemia is frequent, homozygous children, who have slightly lower Hb levels than
normal, have been observed to have significantly reduced risk
of hospital admission with severe malaria (OR: 0.4, 95% CI:
0.22– 0.74) and also of admission with nonmalaria infections

Anemic children in Nigeria come from families with high
infant and child mortality (Fleming and Werblinska 1982). In
detailed investigations by these authors of 59 children with
hematocrit ⬍0.30, the cause was always multiple, associated
with viral or bacterial infections, malaria, sideropenia, folate
deficiency, hypoproteinemia and sickle cell disease. Zucker et
al. (1996) reported primary causation for severely anemic (Hb
⬍50 g/L) hospitalized children in Western Kenya in relation
to mortality (Table 6). This information has been used to
obtain estimates of days of life lost through death for each of
these primary diagnostic categories for severe anemia (Ghana
Health Assessment Team 1981). Specific case definitions for
clinical syndromes were assigned, but some misclassification
may have occurred (e.g., no severe anemia was reported in any
case of measles).
Average age of onset in affected children was assumed to be
1 y and the expectation of life was assumed to be 53 y (Fleming
and Werblinska 1982). The years of healthy life lost per 1000
population per year is calculated as the case fatality rate ⫻ the
annual incidence of severe anemia ⫻ 53. The annual incidence of severe anemia per 1000 live births is calculated as the
annual incidence of death due to anemia/the case fatality rate,
and the annual incidence of deaths due to severe anemia is the
proportion of child deaths attributed to severe anemia ⫻ the
mortality rate for children ⬍ 5 y old. The latter is taken as 90
per 1000 live births for Kenya (United Nations Children’s
Fund 1999).
Table 6 shows the years of life lost because of severe anemia
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TABLE 5
Relative risk of mortality by severity of anemia1
Hb cut-off

Deaths
(sample size)
n

⬍50
⬎50
⬍70
⬎70
⬍50
⬍80
⬎83
⬍50
⬎50
⬍50
⬎50
⬍39
⬍50
⬎50
⬍50
⬎50
⬍50
⬍50
⬍50
⬍40
⬍60
⬍60
⬍50

86 (293)
179 (930)
259 (2471)
187 (9182)
8 (175)
36 (962)
28 (1054)
3 (103)
14 (375)
24 (280)
100 (2060)
56 (174)
89 (416)
136 (1635)
88 (303)
59 (303)
57 (405)
84 (512)
15 (320)
23 (173)
101 (1050)
3 (105)
2 (100)

1.5 (1.2–1.9)
1.0 (referent)
5.2 (4.3–6.2)
1.0 (referent)
1.6 (0.8–3.3)
1.6 (1.0–2.5)
1.0 (referent)
0.8 (0.2–2.6)
1.0 (referent)
1.8 (1.2–2.7)
1.0 (referent)
3.6 (2.8–4.6)
2.6 (2.0–3.3)
1.0 (referent)
1.5 (1.1–2.0)
1.0 (referent)
—
—
—
—
—
—
—

Relative risk B2
(95% CI)

12.1 (8.2–18)
—
4.3 (3.0–6.3)
—
1.9 (0.9–4.1)
1.6 (1.0–2.5)
—
1.2 (0.4–3.9)
3.5 (2.1–5.8)
—
13.3 (8.8–20)
8.9 (6.0–13)
—
12.0 (8.1–18)
—
5.8 (3.8–8.9)
6.8 (4.5–10.2)
1.9 (1.1–3.6)
5.5 (3.3–9.2)
4.0 (2.7–5.9)
1.2 (0.4–3.8)
0.8 (0.2–3.1)

Reference

Zucker et al. 1996
Commey and DeKyem 1995
Schellenberg et al. 1999
Allen et al. 1996
Newton et al. 1997
Lackritz et al. 1992
Lackritz et al. 1997
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g/L

Relative risk A2
(95% CI)

Slutsker et al. 1994
Slutsker et al. 1994
Marsh et al. 1995
Bojang et al. 1997
Brewster and Greenwood 1993
Holzer et al. 1993
Van Hombergh et al. 1996

1 Hb, hemoglobin; CI, confidence interval.
2 A: Own referent group with Hb between 50 and 80 g/L; B: Referent group from Schellenberg et al. 1999; (Hb ⬎8.3 g/L).

from specific causes estimated with this method and using the
published data of Zucker et al. (1996) from Kenya. Malaria and
sepsis are the most important contributors. Symptomatic anemia contributes a substantial burden, and this group probably
includes children with sickle cell disease. It is difficult to
partition iron-deficiency anemia among these diagnoses because it is likely to affect several if not all of these etiological
groups. Malnutrition is not a major contributor to death from
severe anemia.
To attribute more childhood mortality to malarial anemia
than iron-deficiency anemia requires evidence that these two

diagnoses could be distinguished correctly. For this reason,
these estimates in children from Kenya are limited. They can
be compared with data from an iron supplementation and
malaria chemoprophylaxis trial for the prevention of infant
anemia (Hb ⬍80 g/L) in Tanzania (Menendez et al. 1997).
This reported a protective efficacy of 57.3% for malarial anemia and 28.8% for iron-deficiency anemia. The combined
intervention had a more significant effect on anemia than did
the single intervention. A case fatality of 6.1% was reported
for children of all ages from this area with the same level of
anemia (⬍80 g/L) (Schellenberg et al. 1999). Table 7 shows

FIGURE 4 Relative risk for child mortality in relation to hemoglobin (Hb) cut-off points. Log Y ⫽ 1.30 ⫺ 0.137X; R2 ⫽ 13.8%; P ⫽ 0.156.
CI, confidence interval.

FIGURE 5 Survival curves in Malawian infants in relation to hemoglobin (Hb) values (g/L) at 6 mo.
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Illness

Years of
life lost

24.6
52.6
9.5
50.0
0.0
15.0
23.0

10.53
7.47
0.63
0.99
0.0
2.07
2.07

42.8
14.2
6.6
2.0
0.0
13.8
9.0

558.1
395.9
33.4
52.5
0
109.7
109.7

3.4
0.0

22.0
0.0

3.06
0.0

13.9
0.0

162.2
0

DISCUSSION

0.7
1.9

50.0
38.5

0.18
0.63

Days of life lost due to death from different causes of severe
anemia (0 – 4 y)

Malaria
Bacteremia
Malnutrition
HIV2 infection
Diarrhea
Pneumonia
Febrile illness
Symptomatic
anemia
Measles
Chronic
diarrhea
Unclassified

Proportion of
child deaths
attributable
to anemia

Case
fatality
rate

%

%

11.7
8.3
0.7
1.1
0.0
2.3
2.3

Annual
incidence per
10001

0.36
1.6

9.5
33.4

1 Years of life lost per 1000 children 0 – 4 y per year due to death or
illness from severe anemia of that cause.
2 HIV, human immunodeficiency virus.

the infant lives lost because of death from iron deficiency or
malarial anemia estimated from this data. These results support the evidence for a strong link between malaria-related
anemia and child mortality. The contribution of malaria to
iron deficiency is uncertain and research in this area is warranted.
Anemias have been recognized as being associated with
protein-energy malnutrition since the earliest classified descriptions, but the pathogenesis of these anemias is complex
and involves several variables (Dempster et al. 1995, Watt et
al. 1962, Woodruff et al. 1968). Mean Hb values within the
range 80 –110 g/L are usually reported. Few studies give the
proportion of cases with severe anemia, and a recent study
from Kenya found that malnutrition (weight for height ⬍2 SD)
was not associated with severe anemia in hospitalized children
(Lackritz et al. 1997). Risk factors for death have been analyzed mainly in relation to anthropometric assessments, and
there appear to be few data on risk of death in severely anemic
children with malnutrition. Only one identified report compares Hb levels with survival in a group of 80 children with
Kwashiorkor (Tolboom et al. 1986). Fourteen children who
died had a mean Hb value of 90 g/L (17.5%), whereas survivors had a mean value of 97 g/L.
Survival of children with anemia from sickle cell disease in
developing countries is poorly documented. In Ghana, 3.4% of
sickle cell patients in a clinic population were known to have
died (Ohene-Frempong and Nkrumah 1994). Table 3 shows
that in the emergency room at Korle Bu Teaching Hospital,
Ghana, 10.8% of child deaths occurred in children with sickle
cell anemia and in Makerere, Uganda, this value was 1.8%.
The extent to which iron deficiency contributes to these
deaths is unknown. Iron deficiency has been considered uncommon in patients with sickle cell anemia, but reports have
documented the coexistence of severe iron deficiency in sickle
cell patients (Haddy and Castro 1982, Isah and Fleming 1985,
Nkrumah et al. 1984).
The relationship of Hb level to survival has been little
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Death

studied in human immunodeficiency virus (HIV)-infected
children. In HIV-infected European adults with similar CD4
lymphocytic counts and viral load, the most recent value of
Hb was a strong independent prognostic marker for death
(Mocroft et al. 1999). Anemia is a frequent complication of
HIV infection, and its incidence is associated with progression
of HIV disease, prescription of certain chemotherapeutics,
black race and female gender. Anemia, particularly anemia
that does not resolve, is associated with shorter survival of
HIV-infected patients (Sullivan et al. 1998). Table 8 summarizes estimates of deaths in 1990 and deaths projected (year
2000) from iron-deficiency anemia (all forms) published by
Murray and Lopez (1994) in the Global Health Statistics
tabulations on the burden of disease. The burden for mortality
from iron-deficiency anemia is generally greater in girls, with
the highest estimates in China and India, although for boys,
deaths attributable to iron-deficiency anemia were highest in
Latin America and the Caribbean.

TABLE 6

Type of
severe
anemia
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Over half of the children in developing countries suffer
from anemia, with malaria and iron deficiency being the major
etiological factors. In some parts of Africa where malaria
infection is sustained throughout the year, severe anemia is
responsible for more deaths than cerebral malaria (Snow et al.
1994). Increasingly, the contribution of Plasmodium falciparum–associated severe anemia to pediatric mortality is being
recognized, even though the causal relationship between malaria parasitemia and Hb concentration is difficult to establish
because most children in malaria holoendemic areas are harboring parasites continuously. Nevertheless, this analysis suggests that estimates of mortality due to malarial severe anemia
are at least double those for iron-deficiency severe anemia.
Standardized prospective hospital-based or community-based
multicenter studies are needed in areas with different malaria
endemicities to quantify the role of malaria in the causation of
anemia, severe anemia and death from malaria.
Mortality is increased in anemic children with Hb values
⬍50 g/L; the prevalence of such values can approach 3–12%
in high risk populations. The strength of the causal evidence
relating mild-to-moderate anemia to mortality is significantly
weaker. It is critical that this question be resolved with the
strongest possible research design. Even if the RR is low
(⬍1.5), the high prevalence of this condition in developing

TABLE 7
Infant lives lost due to death from iron deficiency or malarial
anemia (Hb ⬍8 g/L)1,2

Attributable
deaths from
anemia

Annual
incidence
anemia
per
person

Annual
mortality
per 1000

YLL

6.1
6.1

0.62
0.36

37.8
22.0

1772.8
1031.8

6.1

0.18

11.0

515.9

Case
fatality
rate
%

All groups
Malaria-related
Iron-deficiency
anemia–related

1 Sources: Estimated from Menendez et al. 1997 and Schellenberg
et al. 1999.
2 YLL, years of life lost; Hb, hemoglobin.
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TABLE 8
Deaths attributable to iron deficiency anemia (all forms) in children1,2
Deaths 1990
Number (thousands)
Region

Rate (per 100,000)

Number (thousands)

Rate (per 100,000)

0–4 y

5–14 y

0–4 y

5–14 y

0–4 y

5–14 y

0–4 y

5–14 y

0
0

0
0

0.4
0.4

0.2
0.2

0
0

0
0

0.3
0.2

0.1
0.1

0
0

0
0

0.5
0.3

0.2
0.2

0
0

0
0

0.4
0.3

0.1
0.1

3
3

2
2

4.3
4.5

1.5
1.6

2
1

1
1

2.7
2.7

0.7
0.7

2
5

1
2

2.7
8.8

0.6
2.0

1
2

0
1

1.4
4.3

0.2
0.7

2
2

1
1

4.0
3.8

0.8
0.7

1
1

0
0

2.6
2.4

0.4
0.4

2
2

1
1

3.6
3.4

1.1
1.2

2
2

1
1

2.6
2.4

0.6
0.6

2
1

1
1

6.5
5.3

1.9
2.3

1
1

1
1

4.5
3.6

1.1
1.3

2
2

2
0

4.4
4.4

3.2
0.8

0
1

0
0

0.8
3.1

0.4
0.4

12
14

5
7

3.6
4.6

0.9
1.2

8
9

3
4

2.4
2.7

0.5
0.6
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EME
Boys
Girls
FSE
Boys
Girls
India
Boys
Girls
China
Boys
Girls
OAI
Boys
Girls
SSA
Boys
Girls
LAC
Boys
Girls
MEC
Boys
Girls
World
Boys
Girls

Deaths 2000 projected

1 EME, established market economies; FSE, formerly socialist economies; OAI, other Asia and islands; SSA, sub-Saharan Africa; LAC, Latin
American countries; MEC: Middle Eastern crescent.
2 Source: Murray and Lopez 1994 and 1996.

countries (40 – 60%) in high risk populations could result in a
significant attributable risk of child mortality. However, given
the general weakness in the causal evidence relating most
iron-deficiency anemia in young children to mortality, it is
premature to generate projections regarding population-attributable risk. If mild-to-moderate disease is not an independent
risk factor for child mortality, then intervention programs
should consider either a test-and-treat approach or have other
justifications for universal supplementation.
The burden of this disease assessed as years of life lost is
large because mortality is highest in the youngest children.
The burden for childhood malarial anemia is greatest in Africa, from where most of the reports originate. Despite the
availability of regional estimates from the global burden of
disease reports, few clinical data were found on mortality in
severely anemic children who were from nonmalarious areas.
For example, the inter-American investigation on mortality in
childhood did not quantify anemia, although malnutrition was
implicated in 56% of all deaths in children 1– 4 y (Puffer and
Serrano 1973). The paucity of information from nonmalarious
locations is a deficiency, and obtaining data from these areas is
a priority. The quantitative effect of anemia on child mortality
will exhibit proportionate change across different populations
with different disease ecology. At times, the etiology of anemia
remains unexplained despite careful investigations (Hendrickse and King 1958), and for some key nutrient deficiencies
associated with anemia (e.g., folate), no information was identified on mortality risk.

Would improving Hb levels by whatever means lead to
reductions in child mortality? Could screening of young children identify those most at risk of death? Further research is
required to answer these questions, but evidence in this analysis would suggest that both approaches might be fruitful.
Primary prevention of iron-deficiency anemia and malaria in
young children could have substantive effects on reducing
child mortality from severe anemia.
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Participants: Premji, Tielsch, Stoltzfus, Brabin, Pelletier,
Lynch, Oppenheimer, Sazawal, Schultink, Levin
Dr. Premji: The sociocultural factor has not really been
mentioned in these discussions, and I would like to comment
as a practicing physician in this area, especially the East
African Coast. We see a lot of severely anemic children being
brought to the hospital and eventually they die. Then you start
talking to the mother and it comes out quite vividly that 7 d
back they had something known as traditional surgery, the
uvulectomy. This actually precipitates acute hemorrhage. This
is also a major problem and a cause of mortality.
In Tanzania, we have something known as the National
Health Management Information System, which was started
about 4 y back. It is collecting data from four health facilities
in Tanzania. Anemia here is the second leading cause of
hospital-based deaths. Number one is malaria. All other anemias are second, at 17.8% of deaths. It is really difficult here to
say whether these are iron-deficiency anemia or other nutritional anemias. So, definitely as a public health issue, anemia
in a malaria endemic area is a big, big problem.
An additional point that was discussed yesterday, which
Brabin found in data from Malawi, is that in the younger age
group more males are affected. In the higher age group, more
females are dying than males. I have not worked out the
concept yet, because as a parasitologist I know that in the
younger age group, mosquitoes do not have any sex bias. They
equally bite the female and male children. I think these are the
first few reports that might be coming out that there is a sex
issue.
Dr. Tielsch: I am going to comment on just a few of the
traditional epidemiological criteria for causal inference that
are most appropriate to this situation. Regarding the strength
of the association, the evidence that Brabin presented and the
clinical experience in general are strong for severe anemia.
There is not much point in arguing about that. As he points
out quite rightfully in his paper, much less so for moderateto-severe anemia. In fact, we are really in a situation where it
is hard to find any evidence at all that there is an association
with mortality.
Another criterion is replicability. For a cut-off level of ⬍50
g/L, the variation went from 3% case fatality all the way to
35% case fatality. That would not fit the epidemiologist’s
criterion for replicability. That kind of variation is just enormous.
Biological plausibility is very strong for severe anemia. The
critical question is related to mild-to-moderate anemia, especially that caused by iron deficiency, because this is where
most of the pool of anemia exists.
In terms of responsiveness to interventions, we do not have
any data. I think this is a clear opening for trials to be done in
this area. The only way we are going to get responsiveness
information is to do some trials. If we did trials that had severe
anemia as the outcome instead of mortality as the outcome, I
would probably be happy, because I am convinced that severe
anemia is a bad thing. You do not want kids to have severe
anemia, so that might be a reasonable surrogate.
What about alternative explanations? Almost all these data
are from hospital-based studies in incredibly resource-poor
settings, where access to care is a huge factor and where
thresholds and criteria for hospital admission are going to vary
dramatically by time and between institutions. Those kinds of
situations make it extremely difficult to disentangle selection
bias from true effects of those particular clinical conditions.
My conclusion is that there is strong evidence for a causal

association of severe anemia and mortality, especially in malaria endemic areas. Little evidence supports a causal association with mild-to-moderate anemia and mortality, nor for
iron-deficiency anemia without malaria, because we have almost no data in that regard. Given the high prevalence of
mild-to-moderate anemia, it is critical to know that this increases mortality in areas both with and without malaria.
Dr. Stoltzfus: The relationship to respiratory infection is
potentially important. In Siaya, Kenya, mortality rates in
hospital went up when hemoglobin levels were below 50 g/L,
but that effect was hugely modified by the presence of respiratory illness in the children. Severe anemia and respiratory
illness is a very deadly combination for a child to have. This
was also apparent in the data that you showed from Kilifi,
Kenya. Now, those were malaria-related deaths, but if you
have a simple severe anemia as opposed to severe anemia with
respiratory distress, the difference in case fatality rates in that
hospital was over 10-fold. It also appears in U. K. adult surgical
data. If you have severe anemia and cardiovascular disease, it
seems like the combination of the low hemoglobin in the
blood and a secondary factor that is affecting oxygen delivery,
such as poor respiratory function, is a particularly bad combination. It makes me think about India and other places where
you do not have malaria but you have lots of children dying
from respiratory-related illness. Can we get data from those
places to look at the combined effects of anemia and respiratory illness on mortality?
Dr. Tielsch: I guess the other question even before that is:
Is this respiratory disease that we see in these malaria hyperendemic areas just another indication of the severity of the
malaria?
Dr. Brabin: It can be answered because it has been studied.
Some of the children do have malaria. However, as a predictor
of outcome, the respiratory distress is closely related to metabolic acidosis rather than pneumonia.
Dr. Sazawal: At least in nonmalarious areas, one of the
strong predictors of pneumonia mortality is oxygen saturation.
In a community setting, if you did oxygen saturation assessment on children presenting with pneumonia to an outpatient
clinic, it strongly correlates with outcome of the pneumonia
episode. I assume on a theoretical basis that in anemic children, given the same degree of the insult, whether it is because
of pneumonia or whether it is because of bronchitis, it is going
to lead to a higher and higher oxygen saturation problem.
Theoretically you could predict it, but there are no direct data.
Dr. Pelletier: Yesterday, Brabin, we listened to your methods and came to the conclusion that most of the anemia
among women was due to iron-deficiency anemia. In your
paper today you are suggesting that it is the reverse. In Africa,
one of the things you hear commonly is that malaria is the
great leveler, that it strikes without regard to socioeconomic
status. Based on the data you presented today, weak as the data
are, we are assuming no relationship, except with severe anemia. That is even though Beard said clearly yesterday that
experimental data suggest that there is an increased risk of
infection during iron deficiency, although a small number of
reports indicate otherwise. He encourages caution in the interpretation of many studies, as the confounding issues of
poverty, generalized malnutrition, and multimicronutrient deficiencies are often present in those studies. He is talking about
iron deficiency and, presumably, if severe enough, iron-deficiency anemia. If all of that is true, if there is an effect of iron
deficiency and all these confounding factors that move in the
same direction, we should be seeing strong effects on child
mortality from poverty, other micronutrients and iron itself.
We are not seeing it. It is consistent with what you have seen
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child. This is the real scenario. It happens quite often. An
acute drop of hemoglobin. Now, that might not be related to
the iron stores of this child, but we do not know exactly what
is happening. There are quite a number of those and I do not
know how you would put that as far as mortality is concerned.
Is it due to malaria? Is it due to anemia, an acute drop in
hemoglobin?
Dr. Pelletier: If the child survives, what happens to the
hemoglobin in the next few days?
Dr. Premji: You give supplements.
Dr. Pelletier: Do you know the normal course?
Dr. Premji: In this case, you have to give a blood transfusion. You may save the child and then you start supplementation. It is a difficult question.
Dr. Lynch: Do they have hemoglobinuria?
Dr. Premji: Some do, but it will still be microscopic, not
macroscopic.
Dr. Brabin: I know exactly what you mean. I think some of
it may be septicemia. You have to try to make a clinical
diagnosis. Some cases cannot be classified.
Dr. Lynch: To go back to the human immunodeficiency
(HIV) question, we should all think very carefully about how
we look at those intervention trials for HIV and be very careful
that we are looking at trials where the iron is being given for
iron deficiency, as far as that can be established. Otherwise
there is the huge risk of quickly building up a body of data that
says iron is bad for HIV anemia. In general, HIV anemia is not
going to be iron deficiency—in Western countries anyway. I
am not sure about Africa.
Dr. Lynch: In an area like Malawi, where 6 –10% of
children have HIV, there is a substantial attributable component of anemia due to HIV. These children are relatively
reasonably clinically well.
Dr. Brabin: They are not iron deficient, are they?
Dr. Lynch: I do not know. They have a low hemoglobin. It
really becomes a crucial issue. If it were true that iron exacerbates HIV infection, it would be the end of iron supplementation, which is why we cannot ignore it.
Dr. Stoltzfus: There is not a lot of purpose in discussing it
at this meeting, because the evidence is so scanty. Our discussion right now is focused on malaria. When we talk about
sub-Saharan Africa, we are talking about iron deficiency and
malaria as competing causes. If we gathered again in 5 y, it
could be iron deficiency and HIV and how to disentangle
them. It also has implications for our problem definition and
surveillance of the problem. As HIV makes its way through
the African continent, prevalence of anemia is going to become a worse and worse indicator for surveillance and monitoring and setting global goals for iron deficiency. All evidence
is that the prevalence of anemia is going to go up.
Dr. Tielsch: Yesterday it was said that we should look at
the full natural course of reproductive outcomes before we
make decisions about whether iron supplementation is beneficial. You need to apply the same thinking to the natural
history of HIV. If iron is at all associated with the underlying
natural history—that is, the progression from infection to
clinical manifestation and then from manifestation to death—
you really need to understand that full course as well and not
just what happens just in one particular scenario. HIV-positive
people with iron deficiency may exhibit their anemia very late
in the course of their HIV disease, and they are much more
ready to die than people who had expressed their clinical
symptomatology earlier. I think it is important to have the full
picture in mind. The vitamin A story reminds me of that,
because the vitamin A story is clearly involved in that whole
natural history process as well.
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in this paper, that maybe malaria is a major cause of anemia
among children and it is the great leveler.
Dr. Tielsch: I would not infer that at all. These are all
hospital-based data from Africa, basically. You have to be
really sick to get admitted to a resource-poor hospital. That is
expressed well by the case fatality rates. Some of those case
fatality rates are astounding.
Dr. Brabin: I think we look at average data. If you look at
all patients and children who are not as sick, malaria is still the
major cause of anemia in young children.
Dr. Stoltzfus: Clara Menendez’s study in Ifikara, Tanzania,
has the best data we have on severe anemia in infancy. With
malaria chemoprophylaxis, the incidence of severe anemia was
reduced about 60% and with the iron supplementation it was
30%. She infers that those proportions are attributable to iron
and malaria and the malaria portion is bigger.
What makes me uncomfortable with that inference is that
her iron supplementation intervention was administered from
2 to 6 mo of age. Most of the severe anemia happened between
6 and 12 mo of age. So, I am not convinced that giving those
children low-dose iron supplements from 2 to 6 mo of age
eliminated iron deficiency in the second half of infancy. Obviously, her intervention pumped up their stores by 6 mo and
decreased greatly the amount of iron deficiency, but 28% is
probably an underestimate. It is inaccurate to infer that that is
the exact amount attributable to iron deficiency in all of
infancy. She was not giving iron supplements during the most
vulnerable period from a nutritional standpoint, when the
children would be the most iron deficient. My point is only
that even in a very high endemic part of Africa, the contribution of iron deficiency is fairly substantial to severe anemia.
Dr. Lynch: I agree with you entirely. It is important to
remember that the young infant is dependent on a daily iron
supply and is not able to build up a big store because of the
physiological fact that the body uses the store first and then it
pumps up the absorption once the store is gone. I think your
inference is very likely.
Dr. Oppenheimer: You cannot completely separate malaria
from iron deficiency when you are looking at hemoglobin as
the outcome. In our study of iron dextran–supplemented infants in Papua New Guinea, although there was a mean
increase in hemoglobin in the intervention group, there was
also an increase in severe anemia in the intervention group.
Those infants in the iron intervention group who had a
positive malaria blood slide had a much lower mean hemoglobin, 70 g/L. For the placebo group, if they had a positive blood
slide, their mean hemoglobin, I think, was 85 g/L. Although
there was an overall improvement in hematological status
measured crudely by hemoglobin, if you are looking at the
high-risk anemia cases, there are more of those in the intervention group.
Dr. Stoltzfus: That was not true in Menendez’s trial and it
was not true in the trial in Zanzibar that we completed that is
still unpublished.
Dr. Oppenheimer: I do not think that should always be the
case, but you have to look for that interaction. You cannot
automatically separate the causes of anemia when you have got
iron in there—you have to look at the interactions.
Dr. Stoltzfus: Right, I agree.
Dr. Premji: Another observation that I often make but
cannot explain: you have a child who comes to the hospital
with, for example, a hemoglobin of 80 –90 g/L, which is not
bad in our settings. The child has high fever, the blood slide is
positive. You may decide to hospitalize this child, maybe for
hyperpyrexia, something of that sort. Within 6 –12 h, the
hemoglobin drops down drastically, and you may lose this
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subsequently rise further with increasing age where hookworm
is common. Hemoglobin ⬍80 g/L was the outcome for that
study.
Dr. Schultink: You know, iron was the last big micronutrient where we still thought we had a good estimate. For
iodine, we had an estimate for goiters, but we do not even start
thinking about the real magnitude of the problem of iodine
deficiency. Still, that does not prevent us from doing something about it. I think that for programmers there is a plus
here: the target in terms of worldwide anemia. Is it the ironattributable anemia? If so, the target is smaller and we need to
recognize where that target is. Then if we can persuade the
programmers to focus their efforts on the iron-deficient segments, if we can identify them, we can certainly stop wasting
a lot of time on treating the part of the target that is not going
to change.
Dr. Levin: Most of these studies are hospital based or
observations from clinics. What is the magnitude of the problem outside the hospital. Getting back to programmatic issues,
how do you address that?
Dr. Stoltzfus: In rural Zanzibar, of children 6 –24 mo of
age, 30% have hemoglobin ⬍70 g/L. These were children who
we assessed as clinically well. If they were clinically ill, we did
not do the health assessment that way that day. So, there is a
huge amount out there.
Dr. Sazawal: What is the prevalence of malaria?
Dr. Stoltzfus: Very, very high, very like the Ifikara population that Menendez studied. So, what proportion of that
severe anemia is due to iron? I think it is higher than we
thought in the past— higher than I thought in the past. At
least 28% of it is. Say that 28% is really 40% or 50%. Then you
are talking about still, on a community level, a large amount
of severe anemia that is attributable to iron deficiency in
malaria-endemic sub-Saharan Africa.
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Dr. Lynch: I think that is actually a very important point.
The effect of iron on HIV may actually be quite different at
different times. It is not necessarily all the same throughout
the disease.
Dr. Pelletier: Maybe this is stating the obvious, but this
whole discussion brings me back to Stoltzfus’s introductory
presentation in which a projection showed that perhaps 80%
of the world’s population is iron deficient in one form or
another or with one manifestation or another. What I am
taking away from this discussion is that, at least Africa and
probably other malarial areas, we actually do not know the
prevalence of iron deficiency, in large part because we do not
have adequate measures and there are so many different causes
of anemia, as measured through hemoglobin. Maybe I am a
slow learner, but that is kind of an astounding conclusion, and
I would like somebody to correct me if I am getting it wrong.
So, we go from 80% to a big question mark.
Dr. Lynch: It is not quite as bad as that. There is reason to
believe—and maybe not absolute evidence, certainly not for
the individual—that you can select certain groups in whom
iron deficiency is going to be a big component. You could
identify some age groups, population groups, and issues—
hookworm obviously is going to be one—where iron deficiency
is going to be highly prevalent. To make a blanket statement
about all of Africa is probably wrong. Certainly in southern
Africa there is reason to believe that iron deficiency is actually
quite uncommon, maybe because of iron pots.
Dr. Sazawal: It is not coming from 80% to zero. In the
Menendez paper, 28% is on the table. Given the data, it is safe
to conclude that at least that part is iron deficiency.
Dr. Brabin: Also, that is with an influence of very low
hookworm infection in infants, whereas hookworm infection
rises dramatically with age. So, that is a kind of common
denominator and prevalence of iron deficiency anaemia may

